SAN DIEGO — Cosmederm Bioscience last week announced that a study recently published in the journal Acta Dermato-Venereologica has established its TriCalm anti-itch product has greater anti-itch efficacy as compared with products containing hydrocortisone or diphenhydramine.
Researchers at the Wake Forest School of Medicine compared a topical hydrogel containing aluminum acetate and strontium (sold commercially as TriCalm Hydrogel) head-to-head against two products commonly marketed for anti-itch. TriCalm was "significantly superior" to the other two over-the-counter anti-itch agents reducing both the peak intensity and duration of the subjects' itch, according to the results of the study.
The double blinded, vehicle-controlled study was looking specifically at non-histamine induced itches. The researchers induced itch in the subjects using a tropical plant called cowhage typically used when studying non-histamine-induced itch.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.